Non-invasive prenatal examination kits
Non-invasive determination of the gender and Rh factor of the child - This is a genetic laboratory diagnostic method that allows you to determine the result from the mother’s blood in early pregnancy (from the 10th week) with an accuracy of 99%. The results of the study are based on the detection of fetal DNA in the blood of a pregnant woman.
Kits are based on the principle of "real-time PCR." In the work, an approach is used that allowed to increase the sensitivity of test systems to identify single fetal DNA molecules in the blood of a pregnant woman. For this, ultra-short probes, unique primers and high-performance polymerases are used.
About product
Diagnostic kits for identification of fetal DNA by maternal blood produced by InBio have Registration Certificate No. ФСР 2010/09565 dated 02/18/2020 issued by ROSZRAVNADZOR.
Test SRY - a test system for non-invasively determining the sex of the fetus from the 10th (embryological) week of pregnancy by the blood of a pregnant woman is of particular importance for families at risk of developing a sex-linked disease.
Test RHD - a test system for non-invasive detection of the gene of the Rh factor of the fetus from the 10th (embryological) week of pregnancy.
Get a commercial offer
Instruction
Set for identification of the SRY gene of the fetus in the blood of the mother "DNA-sex of the child" number of determinations: 30
Set for identification of the SRY gene of the fetus in the blood of the mother "DNA-gender of the child plus" number of determinations: 50/100
Set for identification of the Rh factor gene (RHD) of the fetus in the mother’s blood “DNA-Rh baby” number of determinations: 30
Set for identification of the Rh factor gene (RHD) of the fetus in the mother’s blood “DNA Rh plus” number of determinations: 50/100
EN 
RU